Amyloid-β peptide is needed for cgmp-induced long-term potentiation and memory

Journal of Neuroscience

Volumn 37, Issue 29, 2017, Pages 6926-6937

  Palmeri, Agostino ^a   Ricciarelli, Roberta ^b   Gulisano, Walter ^a   Rivera, Daniela ^b   Rebosio, Claudia ^b   Calcagno, Elisa ^b   Tropea, Maria Rosaria ^a   Conti, Silvia ^f   Das, Utpal ^d   Roy, Subhojit ^d,e   Pronzato, Maria Adelaide ^b   Arancio, Ottavio ^f   Fedele, Ernesto ^b,c   Puzzo, Daniela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f Department of Medicine   (United States)

Author keywords

Amyloid beta; APP; CGMP; Long term potentiation; Memory; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; CYCLIC GMP; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; VARDENAFIL;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HIPPOCAMPAL SLICE; IMMUNOBLOTTING; LONG TERM MEMORY; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRATUM RADIATUM; ANIMAL; C57BL MOUSE; HIPPOCAMPUS; KNOCKOUT MOUSE; MEMORY; METABOLISM; MOUSE; PHYSIOLOGY; RECALL; SPRAGUE DAWLEY RAT; TASK PERFORMANCE;

AMYLOID BETA-PEPTIDES; ANIMALS; CYCLIC GMP; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MEMORY; MENTAL RECALL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS, SPRAGUE-DAWLEY; TASK PERFORMANCE AND ANALYSIS;

EID: 85025125237     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3607-16.2017     Document Type: Article

References (59)

1. Andoh T, Chiueh CC, Chock PB (2003) Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis. J Biol Chem 278:885–890. CrossRef Medline
2. Arancio O, Kandel ER, Hawkins RD (1995 Jul 6) Activity-dependent long-term enhancement of transmitter release by presynaptic 3ʹ,5ʹ-cyclic GMP in cultured hippocampal neurons. Nature 376:74–80. CrossRef Medline
3. Baltrons MA, Pedraza CE, Heneka MT, García A (2002) Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells. Neurobiol Dis 10:139–149. CrossRef Medline
4. Baltrons MA, Pifarré P, Ferrer I, Carot JM, García A (2004) Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains. Neurobiol Dis 17:462–472. CrossRef Medline
5. Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH (1996) Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. Neuroreport 7:585–588. CrossRef Medline
6. Bollen E, Puzzo D, Rutten K, Privitera L, De Vry J, Vanmierlo T, Kenis G, Palmeri A, D’Hooge R, Balschun D, Steinbusch HM, Blokland A, Prickaerts J (2014) Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling. Neuropsychopharmacology 39: 2497–2505. CrossRef Medline
7. Bonkale WL, Winblad B, Ravid R, Cowburn RF (1995) Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer’s disease. Neurosci Lett 187:5–8. CrossRef Medline
8. Broadbent NJ, Gaskin S, Squire LR, Clark RE (2010) Object recognition memory and the rodent hippocampus. Learn Mem 17:5–11. CrossRef Medline
9. Cai ZX, Guo HS, Wang C, Wei M, Cheng C, Yang ZF, Chen YW, Le WD, Li S (2016) Double-edged roles of nitric oxide signaling on APP processing and amyloid-β production in vitro: preliminary evidence from sodium nitroprusside. Neurotox Res 29:21–34. CrossRef
10. Medline Canepa E, Domenicotti C, Marengo B, Passalacqua M, Marinari UM, Pronzato MA, Fedele E, Ricciarelli R (2013) Cyclic adenosine monophosphate as an endogenous modulator of the amyloid-β precursor protein metabolism. IUBMB Life 65:127–133. CrossRef Medline
11. Chalimoniuk M, Strosznajder JB (1998) Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum: effects of amyloid beta peptide. Mol Chem Neuropathol 35:77–95. CrossRef Medline
12. Cheng YF, Wang C, Lin HB, Li YF, Huang Y, Xu JP, Zhang HT (2010) Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats. Psychopharmacology (Berl) 212: 181–191. CrossRef Medline
13. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913–922. CrossRef Medline
14. Das U, Wang L, Ganguly A, Saikia JM, Wagner SL, Koo EH, Roy S (2016) Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci 19:55–64. CrossRef Medline
15. Fedele E, Rivera D, Marengo B, Pronzato MA, Ricciarelli R (2015) Amyloid-beta: walking on the dark side of the moon. Mech Ageing Dev 152:1–4. CrossRef Medline
16. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004) Persistent improvement in synaptic and cognitive functions in an Alzhei- mer mouse model after rolipram treatment. J Clin Invest 114:1624–1634. CrossRef Medline
17. Huang YY, Nguyen PV, Abel T, Kandel ER (1996) Long-lasting forms of synaptic potentiation in the mammalian hippocampus. Learn Mem 3:74– 85. CrossRef Medline
18. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37:925–937. CrossRef Medline
19. Kerppola TK (2006) Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells. Nat Protoc 1:1278–1286. CrossRef Medline
20. Lawrence JL, Tong M, Alfulaij N, Sherrin T, Contarino M, White MM, Bell-inger FP, Todorovic C, Nichols RA (2014) Regulation of presynaptic Ca2+, synaptic plasticity and contextual fear conditioning by a N-terminal β-amyloid fragment. J Neurosci 34:14210–14218. CrossRef Medline
21. Lee HR, Shin HK, Park SY, Kim HY, Lee WS, Rhim BY, Hong KW, Kim CD (2014) Cilostazol suppresses β-amyloid production by activating a dis-integrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β. J Neurosci Res 92:1581–1590. CrossRef Medline
22. 1–42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience 163:741–749. CrossRef Medline
23. Lu YF, Kandel ER, Hawkins RD (1999) Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 19:10250–10261. Medline
24. Monfort P, Muñoz MD, Kosenko E, Felipo V (2002) Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J Neurosci 22:10116–10122. Medline
25. Morales-Corraliza J, Mazzella MJ, Berger JD, Diaz NS, Choi JH, Levy E, Matsuoka Y, Planel E, Mathews PM (2009) In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice. PLoS One 4:e7134. CrossRef Medline
26. Morales-Corraliza J, Schmidt SD, Mazzella MJ, Berger JD, Wilson DA, Wesson DW, Jucker M, Levy E, Nixon RA, Mathews PM (2013) Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer’s disease mouse model. Neurobiol Aging 34:137–145. CrossRef Medline
27. Morley JE, Farr SA, Banks WA, Johnson SN, Yamada KA, Xu L (2010) A physiological role for amyloid-beta protein: enhancement of learning and memory. J Alzheimers Dis 19:441–449. CrossRef Medline
28. O’Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 34:185–204. CrossRef Medline
29. Orejana L, Barros-Miñones L, Jordán J, Puerta E, Aguirre N (2012) Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol Aging 33:625.e11–20. CrossRef Medline
30. Palmeri A, Privitera L, Giunta S, Loreto C, Puzzo D (2013) Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory. Behav Brain Res 240:11–20. CrossRef Medline
31. Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewöhner U, van der Staay FJ, Blokland A, de Vente J (2002) Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 113:351–361. CrossRef Medline
32. Puzzo D, Arancio O (2013) Amyloid-β peptide: Dr. Jekyll or Mr. Hyde? J Alzheimers Dis 33:S111–120. CrossRef Medline
33. Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O (2005) Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 25:6887–6897. CrossRef Medline
34. Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28:14537–14545. CrossRef Medline
35. Puzzo D, Staniszewski A, Deng SX, Privitera L, Leznik E, Liu S, Zhang H, Feng Y, Palmeri A, Landry DW, Arancio O (2009) Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer’s disease mouse model. J Neurosci 29:8075–8086. CrossRef Medline
36. Puzzo D, Privitera L, Fa’ M, Staniszewski A, Hashimoto G, Aziz F, Sakurai M, Ribe EM, Troy CM, Mercken M, Jung SS, Palmeri A, Arancio O (2011) Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69:819–830. CrossRef Medline
37. Puzzo D, Privitera L, Palmeri A (2012) Hormetic effect of amyloid-β peptide in synaptic plasticity and memory. Neurobiol Aging 33:1484.e15–24. CrossRef Medline
38. Puzzo D, Loreto C, Giunta S, Musumeci G, Frasca G, Podda MV, Arancio O, Palmeri A (2014) Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice. Neurobiol Aging 35:520–531. CrossRef Medline
39. Puzzo D, Gulisano W, Arancio O, Palmeri A (2015) The keystone of Alzheimer pathogenesis might be sought in Aβ physiology. Neuroscience 307: 26–36. CrossRef Medline
40. Ricciarelli R, Fedele E (2017) The amyloid cascade hypothesis in Alzheimer’s disease: it’s time to change our mind. Curr Neuropharmacol. Advance online publication. Retrieved January 16, 2017. doi: 10.2174/1570159X15666170116143743. Medline
41. Ricciarelli R, Puzzo D, Bruno O, Canepa E, Gardella E, Rivera D, Privitera L, Domenicotti C, Marengo B, Marinari UM, Palmeri A, Pronzato MA, Arancio O, Fedele E (2014) A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: role of amyloid beta. Ann Neurol 75:602–607. CrossRef Medline
42. Rutten K, Vente JD, Sik A, Ittersum MM, Prickaerts J, Blokland A (2005) The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Behav Brain Res 164:11–16. CrossRef Medline
43. Rutten K, Basile JL, Prickaerts J, Blokland A, Vivian JA (2008) Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. Psychopharmacology (Berl) 196:643– 648. CrossRef Medline
44. Sakurai H, Hanyu H, Sato T, Kume K, Hirao K, Kanetaka H, Iwamoto T (2013) Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer’s disease and cerebrovascular disease: a pilot study. Geriatr Gerontol Int 13:90–97. CrossRef Medline
45. Sannerud R, Esselens C, Ejsmont P, Mattera R, Rochin L, Tharkeshwar AK, De Baets G, De Wever V, Habets R, Baert V, Vermeire W, Michiels C, Groot AJ, Wouters R, Dillen K, Vints K, Baatsen P, Munck S, Derua R, Waelkens E, et al. (2016) Restricted location of PSEN2/γ-secretase determines substrate specificity and generates an intracellular Aβ pool. Cell 166:193–208. CrossRef Medline
46. Shim YS, Pae CU, Kim SW, Kim HW, Kim JC, Koh JS (2011) Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study. Int J Impot Res 23:109–114. CrossRef Medline
47. Son H, Lu YF, Zhuo M, Arancio O, Kandel ER, Hawkins RD (1998) The specific role of cGMP in hippocampal LTP. Learn Mem 5:231–245. Medline
48. Tang Y, Scott DA, Das U, Edland SD, Radomski K, Koo EH, Roy S (2012) Early and selective impairments in axonal transport kinetics of synaptic cargoes induced by soluble amyloid β-protein oligomers. Traffic 13:681– 693. CrossRef Medline
49. Teich AF, Nicholls RE, Puzzo D, Fiorito J, Purgatorio R, Fa’ M, Arancio O (2015) Synaptic therapy in Alzheimer’s disease: a CREB-centric approach. Neurotherapeutics 12:29–41. CrossRef Medline
50. Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283:29615–29619. CrossRef Medline
51. Tyan SH, Shih AY, Walsh JJ, Maruyama H, Sarsoza F, Ku L, Eggert S, Hof PR, Koo EH, Dickstein DL (2012) Amyloid precursor protein (APP) regulates synaptic structure and function. Mol Cell Neurosci 51:43–52. CrossRef Medline
52. Ugarte A, Gil-Bea F, García-Barroso C, Cedazo-Minguez Á, Ramírez MJ, Franco R, García-Osta A, Oyarzabal J, Cuadrado-Tejedor M (2015) Decreased levels of guanosine 3ʹ, 5ʹ-monophosphate (cGMP) in cerebrospi-nal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer’s disease. Neuropathol Appl Neurobiol 41:471– 482. CrossRef Medline
53. Vitolo OV, Sant’Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99:13217–13221. CrossRef Medline
54. Wesson DW, Morales-Corraliza J, Mazzella MJ, Wilson DA, Mathews PM (2013) Chronic anti-murine Aβ immunization preserves odor guided behaviors in an Alzheimer’s β-amyloidosis model. Behav Brain Res 237: 96–102. CrossRef Medline
55. Wilkins HM, Swerdlow RH (2016) Amyloid precursor protein processing and bioenergetics. Brain Res Bull S0361–9230(16)30204–0. CrossRef Medline
56. Xu G, Ran Y, Fromholt SE, Fu C, Yachnis AT, Golde TE, Borchelt DR (2015) Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits. Acta Neuropathol Commun 3:72. CrossRef Medline
57. Yamamoto M, Götz ME, Ozawa H, Luckhaus C, Saito T, Rösler M, Riederer P (2000) Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer’s disease. Biochim Biophys Acta 1535:60–68. CrossRef Medline
58. Zhang J, Guo J, Zhao X, Chen Z, Wang G, Liu A, Wang Q, Zhou W, Xu Y, Wang C (2013) Phosphodiesterase-5 inhibitor sildenafil prevents neu-roinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behav Brain Res 250:230–237. CrossRef Medline
59. Zhu L, Yang JY, Xue X, Dong YX, Liu Y, Miao FR, Wang YF, Xue H, Wu CF (2015) A novel phosphodiesterase-5 inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice model. Mech Ageing Dev 150:34–45. CrossRef Medline